Leveraging Chatbot to Improve PrEP in the Southern United States

Yale University logo

Yale University

Status

Begins enrollment in 1 month

Conditions

PrEP Uptake
PrEP Awareness
HIV Prevention

Treatments

Device: A chatbot designed to promote PrEP awareness and uptake for Black MSM
Other: General educational messages

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05968755
000
2000035242

Details and patient eligibility

About

The purpose of this study is to develop a chatbot intervention to promote PrEP awareness and uptake among Black men who have sex with men (MSM) in the Southern United States.

Full description

In the United States (US), the epicenter of the HIV epidemic is in the South. The HIV-related death rate in the US South is high, but engagement with quality HIV prevention services and care is low. Although only 38% of the US population lives in the South, the region accounts for 51% of new HIV infections. Gay, bisexual, and other men who have sex with men (MSM) account for 60% of new infections among African Americans in the South. Black MSM are one of the most vulnerable groups to HIV transmission in the US. HIV testing and PrEP uptake in Black MSM, however, remain low (10%) due to multiple factors including stigma, sexual-orientation based discrimination and low PrEP awareness among Black MSM. Innovative strategies that motivate and provide guidance for PrEP among Black MSM in the US South are therefore urgently needed. Chatbot technology should be tested and implemented to help improve PrEP awareness and uptake in the US South. In this project, the investigators aim to develop and pilot test to assess the acceptability and feasibility of a chatbot for PrEP awareness and uptake relative to treatment as usual (control).

Enrollment

145 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Being cisgender Black male
  • Being aged ≥ 18 years
  • Having Internet access
  • Speaking English
  • Self-reporting condomless sex with another man in the past 6 months
  • HIV negative or untested.

Exclusion criteria

  • Having lived in the US South less than 3 months
  • Having received antiretroviral therapy (ART) treatment.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

145 participants in 2 patient groups, including a placebo group

Intervention group
Experimental group
Treatment:
Device: A chatbot designed to promote PrEP awareness and uptake for Black MSM
Control group
Placebo Comparator group
Treatment:
Other: General educational messages

Trial contacts and locations

0

Loading...

Central trial contact

Zhao Ni

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems